Drug shortages

Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection

Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Other

Current0409-1752-50Anesthesia
Open FDA's page for this record
Update type
Revised
Initial posting date
02/20/2018
Package NDC
0409-1752-50
Generic name
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Contact info
844-646-4398
Availability
Limited Availability
Related info
Limited Supply Available. Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
Update date
10/29/2026
Dosage form
Injection
Presentation
Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000) (NDC 0409-1752-50)
Company name
Hospira, Inc., a Pfizer Company
Shortage reason
Other
Status
Current
Therapeutic category
Anesthesia
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.